Industry Perspectives
| 3 min read
Qureight’s synthetic study arms validate clinical efficacy in pioneering rare lung disease treatment
AI-enabled analytics platform demonstrates how real-world data used in place of human placebo and control groups can significantly reduce study costs and duration
| 2 min read
Mursla Bio Introduces AI Precision Medicine Platform Built on Organ-Specific EV Isolation from Blood
Enables differentiated AI-powered biomarker discovery and IVD translation for patient stratification, therapeutic monitoring, surrogate markers and other diagnostic development programs
| 2 min read
Bio-Rad has expanded its portfolio of recombinant monoclonal anti-idiotypic antibodies and SpyCatcher reagents, enhancing support for bioanalytical assay development and antibody drug research.
| 5 min read
Cell-free expression systems are transforming membrane protein research by enabling faster, more reliable access to functional proteins for drug discovery applications.
| 7 min read
Monitoring ctDNA enables earlier detection, real-time assessment of treatment response, and more personalized strategies that improve patient outcomes across a range of tumor types.
| 2 min read
Fast Track is designed to facilitate development and expedite review of drugs to treat significant unmet medical need, fostering closer collaboration with the FDA
| 6 min read
Home-based healthcare is emerging as a scalable, cost-effective solution to rising systemic pressures, offering resilience in the face of economic, geopolitical, and operational uncertainty.
| 2 min read
The bioX Genetics Platform provides an advanced trusted research environment where users can access a range of cutting-edge analytical tools to manage and search genetic datasets
| 6 min read
A fragile and complex global supply chain leaves heparin vulnerable to disruption, prompting urgent calls for diversification, regulatory clarity, and investment in synthetic alternatives.
| 2 min read
Two new animal microphysiological system models have been introduced to improve the translatability of preclinical drug safety assessments by enabling early, comparative evaluation of hepatotoxicity across human, rat, and dog Liver-on-a-chip models.
| 3 min read
Paper presents the first pre-clinical application of endogenous antibody recruitment to address multi-drug resistant Gram-negative infections
| 2 min read
Early detection test to be developed in collaboration with the Salford Royal NHS Foundation Trust and the Northern Care Alliance Research Collection biobank
